Dimerix Limited (ASX:DXB)
Australia · Delayed Price · Currency is AUD 0.4500
+0.0100 (2.27%)
Feb 26, 2026, 3:46 PM AEST
Dimerix Market Cap
Dimerix has a market cap or net worth of 264.17 million as of February 25, 2026. Its market cap has increased by 3.98% in one year.
Market Cap
264.17M
Enterprise Value
195.99M
Revenue
5.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.45
Market Cap Chart
Since July 6, 2015, Dimerix's market cap has increased from 13.24M to 264.17M, an increase of 1,895.82%. That is a compound annual growth rate of 32.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 264.17M | -20.00% |
| Dec 31, 2025 | 330.22M | 74.10% |
| Dec 31, 2024 | 189.67M | 117.15% |
| Dec 29, 2023 | 87.35M | 87.74% |
| Dec 30, 2022 | 46.53M | -40.82% |
| Dec 31, 2021 | 78.61M | 69.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immutep | 574.75M |
| Clinuvel Pharmaceuticals | 572.79M |
| Racura Oncology | 432.37M |
| Orthocell | 259.10M |
| Starpharma Holdings | 203.66M |
| Tetratherix | 194.94M |
| Recce Pharmaceuticals | 163.39M |
| Actinogen Medical | 145.40M |